Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 798924, 17 pages
http://dx.doi.org/10.1155/2012/798924
Review Article

Role of Cytokines in Systemic Lupus Erythematosus: Recent Progress from GWAS and Sequencing

1Center for Applied Genomics, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
2Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA

Received 2 December 2011; Revised 24 February 2012; Accepted 24 February 2012

Academic Editor: Andrei Surguchov

Copyright © 2012 John J. Connolly and Hakon Hakonarson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Danchenko, J. A. Satia, and M. S. Anthony, “Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden,” Lupus, vol. 15, no. 5, pp. 308–318, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Mina and H. I. Brunner, “Pediatric lupus-are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?” Rheumatic Disease Clinics of North America, vol. 36, no. 1, pp. 53–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. D. Bustamante, F. M. De La Vega, and E. G. Burchard, “Genomics for the world,” Nature, vol. 475, no. 7355, pp. 163–165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. López, C. Gutiérrez, and A. Suáre, “IL-10 and TNFα Genotypes in SLE,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 838390, 11 pages, 2010. View at Publisher · View at Google Scholar
  5. K. Wang, M. Li, and H. Hakonarson, “Analysing biological pathways in genome-wide association studies,” Nature Reviews Genetics, vol. 11, no. 12, pp. 843–854, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Y. H. Yap and K. N. Lai, “Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 365083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. G. S. Dean, J. Tyrrell-Price, E. Crawley, and D. A. Isenberg, “Cytokines and systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 59, no. 4, pp. 243–251, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Yang and D. J. Klionsky, “Eaten alive: a history of macroautophagy,” Nature Cell Biology, vol. 12, no. 9, pp. 814–822, 2010. View at Google Scholar
  9. S. A. Chung, K. E. Taylor, R. R. Graham et al., “Differential genetic associations for systemic lupus erythematosus based on anti-dsdna autoantibody production,” Plos Genetics, vol. 7, no. 3, Article ID e1001323, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Yang, W. Yang, N. Hirankarn et al., “Elf1 is associated with systemic lupus erythematosus in asian populations,” Human Molecular Genetics, vol. 20, no. 3, Article ID ddq474, pp. 601–607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Yang, N. Shen, D. Q. Ye et al., “Genome-wide association study in asian populations identifies variants in ets1 and wdfy4 associated with systemic lupus erythematosus,” Plos Genetics, vol. 6, no. 2, Article ID e1000841, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Han, H. F. Zheng, Y. Cui et al., “Genome-wide association study in a chinese han population identifies nine new susceptibility loci for systemic lupus erythematosus,” Nature Genetics, vol. 41, no. 11, pp. 1234–1237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. R. Graham, C. Cotsapas, L. Davies et al., “Genetic variants near tnfaip3 on 6q23 are associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 9, pp. 1059–1061, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. Harley, M. E. Alarcón-Riquelme, L. A. Criswell et al., “Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in itgam, pxk, kiaa1542 and other loci,” Nature Genetics, vol. 40, no. 2, pp. 204–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Hom, R. R. Graham, B. Modrek et al., “Association of systemic lupus erythematosus with c8orf13-blk and itgam-itgax,” New England Journal of Medicine, vol. 358, no. 9, pp. 900–909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. V. Kozyrev, A. K. Abelson, J. Wojcik et al., “Functional variants in the b-cell gene bank1 are associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 2, pp. 211–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. C. Grumet, A. Coukell, J. G. Bodmer, W. F. Bodmer, and H. O. McDevitt, “Histocompatibility (hl-a) antigens associated with systemic lupus erythematosus. a possible genetic predisposition to disease,” New England Journal of Medicine, vol. 285, no. 4, pp. 193–196, 1971. View at Google Scholar · View at Scopus
  18. S. Beck, D. Geraghty, H. Inoko, and L. Rowen, “Complete sequence and gene map of a human major histocompatibility complex,” Nature, vol. 401, no. 6756, pp. 921–923, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. R. R. Graham, W. A. Ortmann, C. D. Langefeld et al., “Visualizing human leukocyte antigen class ii risk haplotypes in human systemic lupus erythematosus,” American Journal of Human Genetics, vol. 71, no. 3, pp. 543–553, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. D. G. Doherty, R. Ireland, A. G. Demaine et al., “Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern chinese,” Arthritis and Rheumatism, vol. 35, no. 6, pp. 641–646, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. G. H. Hong, H. Y. Kim, F. Takeuchi et al., “Association of complement c4 and hla-dr alleles with systemic lupus erythematosus in koreans,” Journal of Rheumatology, vol. 21, no. 3, pp. 442–447, 1994. View at Google Scholar · View at Scopus
  22. H. Hashimoto, H. Tsuda, and T. Matsumoto, “Hla antigens associated with systemic lupus erythematosus in japan,” Journal of Rheumatology, vol. 12, no. 5, pp. 919–923, 1985. View at Google Scholar · View at Scopus
  23. Y. J. Yuan, X. B. Luo, and N. Shen, “Current advances in lupus genetic and genomic studies in asia,” Lupus, vol. 19, no. 12, pp. 1374–1383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Gateva, J. K. Sandling, G. Hom et al., “A large-scale replication study identifies tnip1, prdm1, jazf1, uhrf1bp1 and il10 as risk loci for systemic lupus erythematosus,” Nature Genetics, vol. 41, no. 11, pp. 1228–1233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. J. Arason, G. H. Jorgensen, and B. R. Ludviksson, “Primary immunodeficiency and autoimmunity: lessons from human diseases,” Scandinavian Journal of Immunology, vol. 71, no. 5, pp. 317–328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. C. Pickering, M. Botto, P. R. Taylor, P. J. Lachmann, and M. J. Walport, “Systemic lupus erythematosus, complement deficiency, and apoptosis,” Advances in Immunology, vol. 76, pp. 227–324, 2000. View at Google Scholar · View at Scopus
  27. K. E. Sullivan, “Complement deficiency and autoimmunity,” Current Opinion in Pediatrics, vol. 10, no. 6, pp. 600–606, 1998. View at Google Scholar · View at Scopus
  28. K. E. Sullivan, J. J. Wisnieski, J. A. Winkelstein et al., “Serum complement determinations in patients with quiescent systemic lupus erythematosus,” Journal of Rheumatology, vol. 23, no. 12, pp. 2063–2067, 1996. View at Google Scholar · View at Scopus
  29. H. Dunckley, P. A. Gatenby, B. Hawkins, S. Naito, and S. W. Serjeantson, “Deficiency of c4a is a genetic determinant of systemic lupus erythematosus in three ethnic groups,” Journal of Immunogenetics, vol. 14, no. 4-5, pp. 209–218, 1987. View at Google Scholar · View at Scopus
  30. H. Miyagawa, M. Yamai, D. Sakaguchi et al., “Association of polymorphisms in complement component c3 gene with susceptibility to systemic lupus erythematosus,” Rheumatology, vol. 47, no. 2, pp. 158–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Sekine, R. C. Ferreira, Q. Pan-Hammarström et al., “Role for msh5 in the regulation of ig class switch recombination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 17, pp. 7193–7198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. M. Fernando, C. R. Stevens, P. C. Sabeti et al., “Identification of two independent risk factors for lupus within the MHC in United Kingdom families.,” Plos Genetics, vol. 3, no. 11, article e192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. B. H. Luo, C. V. Carman, and T. A. Springer, “Structural basis of integrin regulation and signaling,” Annual Review of Immunology, vol. 25, pp. 619–647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Marnell, C. Mold, and T. W. Du Clos, “C-reactive protein: ligands, receptors and role in inflammation,” Clinical Immunology, vol. 117, no. 2, pp. 104–111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. E. V. Lourenço and A. La Cava, “Cytokines in systemic lupus erythematosus,” Current Molecular Medicine, vol. 9, no. 3, pp. 242–254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Antoni and J. Braun, “Side effects of anti-tnf therapy: current knowledge,” Clinical and Experimental Rheumatology, vol. 20, no. 6, supplement 28, pp. S-152–S-157, 2002. View at Google Scholar · View at Scopus
  37. L. J. Zhu, X. Yang, and X. Q. Yu, “Anti-TNF-α therapies in systemic lupus erythematosus,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 465898, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Banchereau, V. Pascual, and A. K. Palucka, “Autoimmunity through cytokine-induced dendritic cell activation,” Immunity, vol. 20, no. 5, pp. 539–550, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Ohshima, Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse, “Expression and function of ox40 ligand on human dendritic cells,” Journal of Immunology, vol. 159, no. 8, pp. 3838–3848, 1997. View at Google Scholar · View at Scopus
  40. U. Latza, H. Durkop, S. Schnittger et al., “The human ox40 homolog: cdna structure, expression and chromosomal assignment of the act35 antigen,” European Journal of Immunology, vol. 24, no. 3, pp. 677–683, 1994. View at Google Scholar · View at Scopus
  41. D. S. C. Graham, R. R. Graham, H. Manku et al., “Polymorphism at the tnf superfamily gene tnfsf4 confers susceptibility to systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 1, pp. 83–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Sanchez, A. Nadig, B. C. Richardson et al., “Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 70, no. 10, pp. 1752–1757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. J. S. Bates, C. J. Lessard, J. M. Leon et al., “Meta-analysis and imputation identifies a 109kb risk haplotype spanning tnfaip3 associated with lupus nephritis and hematologic manifestations,” Genes and Immunity, vol. 10, no. 5, pp. 470–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. S. L. Musone, K. E. Taylor, T. T. Lu et al., “Multiple polymorphisms in the tnfaip3 region are independently associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 9, pp. 1062–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Adrianto, F. Wen, A. Templeton et al., “Association of a functional variant downstream of tnfaip3 with systemic lupus erythematosus,” Nature Genetics, vol. 43, no. 3, pp. 253–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. R. R. Graham, C. Kyogoku, S. Sigurdsson et al., “Three functional variants of ifn regulatory factor 5 (irf5) define risk and protective haplotypes for human lupus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 16, pp. 6758–6763, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Kawasaki, S. Ito, H. Furukawa et al., “Association of tnfaip3 interacting protein 1, tnip1 with systemic lupus erythematosus in a japanese population: a case-control association study,” Arthritis Research & Therapy, vol. 12, no. 5, p. R174, 2010. View at Google Scholar · View at Scopus
  48. S. Basu, K. R. Rosenzweig, M. Youmell, and B. D. Price, “The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage,” Biochemical and Biophysical Research Communications, vol. 247, no. 1, pp. 79–83, 1998. View at Google Scholar
  49. K. Heyninck and R. Beyaert, “A20 inhibits nf-κb activation by dual ubiquitin-editing functions,” Trends in Biochemical Sciences, vol. 30, no. 1, pp. 1–4, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. P. K. Gregersen and L. M. Olsson, “Recent advances in the genetics of autoimmune disease,” Annual Review of Immunology, vol. 27, pp. 363–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. L. E. Ronnblom, K. E. Oberg, and G. V. Alm, “Possible induction of systemic lupus erythematosus by interferon α-treatment in a patient with a malignant carcinoid tumour,” Journal of Internal Medicine, vol. 227, no. 3, pp. 207–210, 1990. View at Google Scholar · View at Scopus
  52. V. Ho, A. McLean, and S. Terry, “Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C,” Journal of Clinical Rheumatology, vol. 14, no. 3, pp. 166–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. C. E. Weckerle, B. S. Franek, J. A. Kelly et al., “Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 63, no. 4, pp. 1044–1053, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. B. J. Barnes, P. A. Moore, and P. M. Pitha, “Virus-specific activation of a novel interferon regulatory factor, irf-5, results in the induction of distinct interferon α genes,” Journal of Biological Chemistry, vol. 276, no. 26, pp. 23382–23390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. R. R. Graham, S. V. Kozyrev, E. C. Baechler et al., “A common haplotype of interferon regulatory factor 5 (irf5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus,” Nature Genetics, vol. 38, no. 5, pp. 550–555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Y. K. Demirci, S. Manzi, R. Ramsey-Goldman et al., “Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE),” Annals of Human Genetics, vol. 71, no. 3, pp. 308–311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. H. D. Shin, Y. K. Sung, C. B. Choi, S. O. Lee, H. W. Lee, and S. C. Bae, “Replication of the genetic effects of ifn regulatory factor 5 (irf5) on systemic lupus erythematosus in a korean population,” Arthritis Research and Therapy, vol. 9, article no. R32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Kawasaki, C. Kyogoku, J. Ohashi et al., “Association of irf5 polymorphisms with systemic lupus erythematosus in a japanese population: support for a crucial role of intron 1 polymorphisms,” Arthritis and Rheumatism, vol. 58, no. 3, pp. 826–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. H. O. Siu, W. Yang, C. S. Lau et al., “Association of a haplotype of irf5 gene with systemic lupus erythematosus in chinese,” Journal of Rheumatology, vol. 35, no. 2, pp. 360–362, 2008. View at Google Scholar · View at Scopus
  60. T. B. Niewold, J. A. Kelly, S. N. Kariuki et al., “IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 71, no. 3, pp. 463–468, 2012. View at Google Scholar
  61. J. A. Kelly, J. M. Kelley, K. M. Kaufman et al., “Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in african americans,” Genes and Immunity, vol. 9, no. 3, pp. 187–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. T. B. Niewold, J. A. Kelly, M. H. Flesch, L. R. Espinoza, J. B. Harley, and M. K. Crow, “Association of the irf5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients,” Arthritis and Rheumatism, vol. 58, no. 8, pp. 2481–2487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Sigurdsson, H. H. H. Göring, G. Kristjansdottir et al., “Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (irf5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus,” Human Molecular Genetics, vol. 17, no. 6, pp. 872–881, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. S. E. Löfgren, H. Yin, A. M. Delgado-Vega et al., “Promoter insertion/deletion in the irf5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells,” Journal of Rheumatology, vol. 37, no. 3, pp. 574–578, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Zhang and J. S. Pagano, “Structure and function of irf-7,” Journal of Interferon and Cytokine Research, vol. 22, no. 1, pp. 95–101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Salloum, B. S. Franek, S. N. Kariuki et al., “Genetic variation at the irf7/phrf1 locus is associated with autoantibody profile and serum interferon-α activity in lupus patients,” Arthritis and Rheumatism, vol. 62, no. 2, pp. 553–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. P. L. De Jager, X. Jia, J. Wang et al., “Meta-analysis of genome scans and replication identify cd6, irf8 and tnfrsf1a as new multiple sclerosis susceptibility loci,” Nature Genetics, vol. 41, no. 7, pp. 776–782, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Hikami, A. Kawasaki, I. Ito et al., “Association of a functional polymorphism in the 3'-untranslated region of spi1 with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 63, no. 3, pp. 755–763, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. A. A. Yee, P. Yin, D. P. Siderovski, T. W. Mak, D. W. Litchfield, and C. H. Arrowsmith, “Cooperative interaction between the dna-binding domains of pu.1 and irf4,” Journal of Molecular Biology, vol. 279, no. 5, pp. 1075–1083, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. W. Huang, E. Horvath, and E. A. Eklund, “Pu.1, interferon regulatory factor (irf) 2, and the interferon consensus sequence-binding protein (icsbp/irf8) cooperate to activate nf1 transcription in differentiating myeloid cells,” Journal of Biological Chemistry, vol. 282, no. 9, pp. 6629–6643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. S. N. Kariuki, K. A. Kirou, E. J. MacDermott, L. Barillas-Arias, M. K. Crow, and T. B. Niewold, “Cutting edge: autoimmune disease risk variant of stat4 confers increased sensitivity to ifn-α in lupus patients in vivo,” Journal of Immunology, vol. 182, no. 1, pp. 34–38, 2009. View at Google Scholar · View at Scopus
  72. E. F. Remmers, R. M. Plenge, A. T. Lee et al., “Stat4 and the risk of rheumatoid arthritis and systemic lupus erythematosus,” New England Journal of Medicine, vol. 357, no. 10, pp. 977–986, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. N. G. Jacobson, S. J. Szabo, R. M. Weber-Nordt et al., “Interleukin 12 signaling in t helper type 1 (th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (stat)3 and stat4,” Journal of Experimental Medicine, vol. 181, no. 5, pp. 1755–1762, 1995. View at Google Scholar · View at Scopus
  74. W. T. Watford, B. D. Hissong, J. H. Bream, Y. Kanno, L. Muul, and J. J. O'Shea, “Signaling by il-12 and il-23 and the immunoregulatory roles of stat4,” Immunological Reviews, vol. 202, pp. 139–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Namjou, A. L. Sestak, D. L. Armstrong et al., “High-density genotyping of stat4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups,” Arthritis and Rheumatism, vol. 60, no. 4, pp. 1085–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Sigurdsson, G. Nordmark, S. Garnier et al., “A risk haplotype of stat4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsdna and shows additive effects with two risk alleles of irf5,” Human Molecular Genetics, vol. 17, no. 18, pp. 2868–2876, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. A. K. Abelson, A. M. Delgado-Vega, S. V. Kozyrev et al., “Stat4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with irf5 to increase risk,” Annals of the Rheumatic Diseases, vol. 68, no. 11, pp. 1746–1753, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. R. De Waal Malefyt, J. Haanen, H. Spits et al., “Interleukin 10 (il-10) and viral il-10 strongly reduce antigen-specific human t cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class ii major histocompatibility complex expression,” Journal of Experimental Medicine, vol. 174, no. 4, pp. 915–924, 1991. View at Google Scholar · View at Scopus
  79. D. F. Fiorentino, M. W. Bond, and T. R. Mosmann, “Two types of mouse t helper cell. iv. th2 clones secrete a factor that inhibits cytokine production by th1 clones,” Journal of Experimental Medicine, vol. 170, no. 6, pp. 2081–20095, 1989. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Eskdale, P. Wordsworth, S. Bowman, M. Field, and G. Gallagher, “Association between polymorphisms at the human il-10 locus and systemic lupus erythematosus,” Tissue Antigens, vol. 49, no. 6, pp. 635–639, 1997. View at Google Scholar · View at Scopus
  81. R. Mehrian, F. P. Quismorio Jr., G. Strassmann et al., “Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 41, no. 4, pp. 596–602, 1998. View at Google Scholar
  82. W. P. Chong, W. K. Ip, W. H. S. Wong, C. S. Lau, T. M. Chan, and Y. L. Lau, “Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus,” Genes and Immunity, vol. 5, no. 6, pp. 484–492, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. F. Rousset, E. Garcia, T. Defrance et al., “Interleukin 10 is a potent growth and differentiation factor for activated human b lymphocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 5, pp. 1890–1893, 1992. View at Google Scholar · View at Scopus
  84. E. Hagiwara, M. F. Gourley, S. Lee, and D. M. Klinman, “Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-γ-secreting cells in the peripheral blood,” Arthritis and Rheumatism, vol. 39, no. 3, pp. 379–385, 1996. View at Publisher · View at Google Scholar · View at Scopus
  85. C. J. Edwards-Smith, J. R. Jonsson, D. M. Purdie, A. Bansal, C. Shorthouse, and E. E. Powell, “Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis c to interferon alfa,” Hepatology, vol. 30, no. 2, pp. 526–530, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Eskdale, G. Gallagher, C. L. Verweij, V. Keijsers, R. G. J. Westendorp, and T. W. J. Huizinga, “Interleukin 10 secretion in relation to human il-10 locus haplotypes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9465–9470, 1998. View at Publisher · View at Google Scholar · View at Scopus
  87. D. M. Turner, D. M. Williams, D. Sankaran, M. Lazarus, P. J. Sinnott, and I. V. Hutchinson, “An investigation of polymorphism in the interleukin-10 gene promoter,” European Journal of Immunogenetics, vol. 24, no. 1, pp. 1–8, 1997. View at Google Scholar · View at Scopus
  88. A. M. Summers, C. W. Summers, D. B. Drucker, A. H. Hajeer, A. Barson, and I. V. Hutchinson, “Association of il-10 genotype with sudden infant death syndrome,” Human Immunology, vol. 61, no. 12, pp. 1270–1273, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. S. G. Guerra, D. L. Morris, V. Gateva, R. R. Graham, T. J. Vyse, and D. S. C. Graham, “Dense mapping of il18 shows no association in sle,” Human Molecular Genetics, vol. 20, no. 5, Article ID ddq536, pp. 1026–1033, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. B. Yu, M. Guan, Y. Peng et al., “Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus,” Arthritis Rheum, vol. 63, no. 11, pp. 3487–3492, 2011. View at Google Scholar
  91. J. Li, H. F. Pan, H. Cen et al., “Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus,” Mol Biol Rep, vol. 38, no. 6, pp. 4077–4081, 2011. View at Google Scholar
  92. C. O. Jacob, J. Zhu, D. L. Armstrong et al., “Identification of irak1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 15, pp. 6256–6261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Webb, J. D. Wren, M. Jeffries et al., “Variants within mecp2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 60, no. 4, pp. 1076–1084, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. A. L. Sestak, B. G. Furnrohr, J. B. Harley, J. T. Merrill, and B. Namjou, “The genetics of systemic lupus erythematosus and implications for targeted therapy,” Annals of the Rheumatic Diseases, vol. 70, supplement 1, pp. 37–43, 2011. View at Google Scholar
  95. A. H. Sawalha, R. Webb, S. Han et al., “Common variants within mecp2 confer risk of systemic lupus erythematosus,” Plos One, vol. 3, no. 3, Article ID e1727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. Fan, J. H. Tao, L. P. Zhang, L. H. Li, and D. Q. Ye, “Association of blk (rs13277113, rs2248932) polymorphism with systemic lupus erythematosus: a meta-analysis,” Molecular Biology Reports, vol. 38, no. 7, pp. 4445–4453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. S. F. A. Grant, M. Petri, J. P. Bradfield et al., “Association of the BANK1 r61h variant with systemic lupus erythematosus in americans of european and african ancestry,” Application of Clinical Genetics, vol. 2009, article 2, pp. 1–5, 2008. View at Google Scholar · View at Scopus
  98. E. Sanchez, M. E. Comeau, B. I. Freedman et al., “Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study,” Arthritis & Rheumatism, vol. 63, no. 11, pp. 3493–3501, 2011. View at Google Scholar
  99. S. Cohen, H. Dadi, E. Shaoul, N. Sharfe, and C. M. Roifman, “Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, lyp,” Blood, vol. 93, no. 6, pp. 2013–2024, 1999. View at Google Scholar · View at Scopus
  100. N. Bottini, L. Musumeci, A. Alonso et al., “A functional variant of lymphoid tyrosine phosphatase is associated with type i diabetes,” Nature Genetics, vol. 36, no. 4, pp. 337–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. M. R. Velaga, V. Wilson, C. E. Jennings et al., “The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (lyp) gene is a major determinant of graves' disease,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5862–5865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. D. Smyth, J. D. Cooper, J. E. Collins et al., “Replication of an association between the lymphoid tyrosine phosphatase locus (lyp/ptpn22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus,” Diabetes, vol. 53, no. 11, pp. 3020–3023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Skorka, T. Bednarczuk, E. Bar-Andziak, J Nauman, and R. Ploski, “Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset,” Clinical Endocrinology, vol. 62, no. 6, pp. 679–682, 2005. View at Google Scholar
  104. L. A. Criswell, K. A. Pfeiffer, R. F. Lum et al., “Analysis of families in the multiple autoimmune disease genetics consortium (madgc) collection: the ptpn22 620w allele associates with multiple autoimmune phenotypes,” American Journal of Human Genetics, vol. 76, no. 4, pp. 561–571, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. C. Vandiedonck, C. Capdevielle, M. Giraud et al., “Association of the ptpn22*r620w polymorphism with autoimmune myasthenia gravis,” Annals of Neurology, vol. 59, no. 2, pp. 404–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. P. Dieude, M. Guedj, J. Wipff et al., “The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis,” Arthritis & Rheumatism, vol. 58, no. 7, pp. 2183–2188, 2008. View at Google Scholar
  107. G. S. LaBerge, D. C. Bennett, P. R. Fain, and R. A. Spritz, “PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not,” Journal of Investigative Dermatology, vol. 128, no. 7, pp. 1757–1762, 2008. View at Google Scholar
  108. B. Skinningsrud, E. S. Husebye, K. Gervin et al., “Mutation screening of ptpn22: association of the 1858t-allele with addison's disease,” European Journal of Human Genetics, vol. 16, no. 8, pp. 977–982, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. R. C. Betz, K. Konig, A. Flaquer et al., “The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata,” British Journal of Dermatology, vol. 158, no. 2, pp. 389–391, 2008. View at Google Scholar
  110. A. Hinks, A. Barton, S. John et al., “Association between the ptpn22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a uk population: further support that ptpn22 is an autoimmunity gene,” Arthritis and Rheumatism, vol. 52, no. 6, pp. 1694–1699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. M. K. Viken, S. S. Amundsen, T. K. Kvien et al., “Association analysis of the 1858c> t polymorphism in the ptpn22 gene in juvenile idiopathic arthritis and other autoimmune diseases,” Genes and Immunity, vol. 6, no. 3, pp. 271–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. M. F. Seldin, R. Shigeta, K. Laiho et al., “Finnish case-control and family studies support ptpn22 r620w polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis,” Genes and Immunity, vol. 6, no. 8, pp. 720–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. J. C. Barrett, S. Hansoul, D. L. Nicolae et al., “Genome-wide association defines more than 30 distinct susceptibility loci for crohn's disease,” Nature Genetics, vol. 40, no. 8, pp. 955–962, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. S. N. Kariuki and T. B. Niewold, “Genetic regulation of serum cytokines in systemic lupus erythematosus,” Translational Research, vol. 155, no. 3, pp. 109–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. T. Vang, A. V. Miletic, N. Bottini, and T. Mustelin, “Protein tyrosine phosphatase ptpn22 in human autoimmunity,” Autoimmunity, vol. 40, no. 6, pp. 453–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Rieck, A. Arechiga, S. Onengut-Gumuscu, C. Greenbaum, P. Concannon, and J. H. Buckner, “Genetic variation in ptpn22 corresponds to altered function of t and b lymphocytes,” Journal of Immunology, vol. 179, no. 7, pp. 4704–4710, 2007. View at Google Scholar · View at Scopus
  117. Y. Deng and B. P. Tsao, “Genetic susceptibility to systemic lupus erythematosus in the genomic era,” Nature Reviews Rheumatology, vol. 6, no. 12, pp. 683–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. J. C. Crispín, S. A. Apostolidis, M. I. Finnell, and G. C. Tsokos, “Induction of pp2a bβ, a regulator of il-2 deprivation-induced t-cell apoptosis, is deficient in systemic lupus erythematosus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 30, pp. 12443–12448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. F. Nimmerjahn and J. V. Ravetch, “Fcγ receptors: old friends and new family members,” Immunity, vol. 24, no. 1, pp. 19–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. E. U. Rudge, A. J. Cutler, N. R. Pritchard, and K. G. C. Smith, “Interleukin 4 reduces expression of inhibitory receptors on b cells and abolishes cd22 and fcγrii-mediated b cell suppression,” Journal of Experimental Medicine, vol. 195, no. 8, pp. 1079–1085, 2002. View at Publisher · View at Google Scholar · View at Scopus
  121. J. I. Robinson, J. H. Barrett, J. C. Taylor et al., “Dissection of the fcgr3a association with ra: increased association in men and with autoantibody positive disease,” Annals of the Rheumatic Diseases, vol. 69, no. 6, pp. 1054–1057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. R. G. Bredius, C. E. de Vries, A. Troelstra et al., “Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2,” The Journal of Immunology, vol. 151, no. 3, pp. 1463–1472, 1993. View at Google Scholar
  123. F. B. Karassa, M. Bijl, K. A. Davies et al., “Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis,” Arthritis & Rheumatism, vol. 48, no. 7, pp. 1930–1938, 2003. View at Google Scholar
  124. N. Tsuchiya, Z. I. Honda, and K. Tokunaga, “Role of b cell inhibitory receptor polymorphisms in systemic lupus erythematosus: a negative times a negative makes a positive,” Journal of Human Genetics, vol. 51, no. 9, pp. 741–750, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. K. Su, X. Li, J. C. Edberg, J. Wu, P. Ferguson, and R. P. Kimberly, “A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function,” The Journal of Immunology, vol. 172, no. 11, pp. 7192–7199, 2004. View at Google Scholar
  126. H. Kono, C. Kyogoku, T. Suzuki et al., “Fcγriib ile232thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on b cell receptor signaling,” Human Molecular Genetics, vol. 14, no. 19, pp. 2881–2892, 2005. View at Publisher · View at Google Scholar · View at Scopus
  127. R. A. Floto, M. R. Clatworthy, K. R. Heilbronn et al., “Loss of function of a lupus-associated fcγriib polymorphism through exclusion from lipid rafts,” Nature Medicine, vol. 11, no. 10, pp. 1056–1058, 2005. View at Publisher · View at Google Scholar · View at Scopus
  128. H. R. Koene, M. Kleijer, A. J. Swaak et al., “The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 41, no. 10, pp. 1813–1818, 1998. View at Google Scholar
  129. G. S. Alarcón, G. McGwin, M. Petri et al., “Time to renal disease and end-stage renal disease in profile: a multiethnic lupus cohort,” Plos Medicine, vol. 3, no. 10, article e396, pp. 1949–1956, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. H. A. Niederer, L. C. Willcocks, T. F. Rayner et al., “Copy number, linkage disequilibrium and disease association in the fcgr locus,” Human Molecular Genetics, vol. 19, no. 16, Article ID ddq216, pp. 3282–3294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  131. Y. Hatta, N. Tsuchiya, J. Ohashi et al., “Association of fcγ receptor iiib, but not of fcγ receptor iia and iiia, polymorphisms with systemic lupus erythematosus in japanese,” Genes and Immunity, vol. 1, no. 1, pp. 53–60, 1999. View at Google Scholar · View at Scopus
  132. H. Yuan, J. D. Ni, H. F. Pan, L. H. Li, J. B. Feng, and D. Q. Ye, “Lack of association of FcgammaRIIIb polymorphisms with systemic lupus erythematosus: a meta-analysis,” Rheumatology International, vol. 31, no. 8, pp. 1017–1021, 2011. View at Google Scholar
  133. A. Franke, D. P. B. McGovern, J. C. Barrett et al., “Genome-wide meta-analysis increases to 71 the number of confirmed crohn's disease susceptibility loci,” Nature Genetics, vol. 42, no. 12, pp. 1118–1125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. P. K. Gregersen, C. I. Amos, A. T. Lee et al., “Rel, encoding a member of the nf-b family of transcription factors, is a newly defined risk locus for rheumatoid arthritis,” Nature Genetics, vol. 41, no. 7, pp. 820–823, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. P. E. Stuart, R. P. Nair, E. Ellinghaus et al., “Genome-wide association analysis identifies three psoriasis susceptibility loci,” Nature Genetics, vol. 42, no. 11, pp. 1000–1004, 2010. View at Google Scholar
  136. S. P. Dickson, K. Wang, I. Krantz, H. Hakonarson, and D. B. Goldstein, “Rare variants create synthetic genome-wide associations,” Plos Biology, vol. 8, no. 1, article 1000294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. H. C. So, A. H. Gui, S. S. Cherny, and P. C. Sham, “Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases,” Genetic Epidemiology, vol. 35, no. 5, pp. 310–317, 2011. View at Publisher · View at Google Scholar · View at Scopus
  138. D. Deapen, A. Escalante, L. Weinrib et al., “A revised estimate of twin concordance in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 35, no. 3, pp. 311–318, 1992. View at Google Scholar · View at Scopus
  139. D. Alarcon-Segovia, M. E. Alarcon-Riquelme, M. H. Cardiel et al., “Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort,” Arthritis & Rheumatism, vol. 52, no. 4, pp. 1138–1147, 2005. View at Google Scholar
  140. J. Wang, S. Yang, J. J. Chen et al., “Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from china,” Archives of Dermatological Research, vol. 298, no. 10, pp. 485–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. S. Song and M. A. Black, “Microarray-based gene set analysis: a comparison of current methods,” Bmc Bioinformatics, vol. 9, article no. 502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  142. J. Hedegaard, C. Arce, S. Bicciato et al., “Methods for interpreting lists of affected genes obtained in a DNA microarray experiment,” BMC Proceedings, vol. 3, supplement 4, p. S5, 2009. View at Google Scholar
  143. J. Glas, J. Seiderer, M. Nagy et al., “Evidence for stat4 as a common autoimmune gene: rs7574865 is associated with colonic crohn's disease and early disease onset,” Plos One, vol. 5, no. 4, Article ID e10373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  144. A. Martinez, J. Varade, A. Marquez et al., “Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases,” Arthritis Rheum, vol. 58, no. 9, pp. 2598–2602, 2008. View at Google Scholar
  145. A. Zhernakova, E. M. Festen, L. Franke et al., “Genetic analysis of innate immunity in crohn's disease and ulcerative colitis identifies two susceptibility loci harboring card9 and il18rap,” American Journal of Human Genetics, vol. 82, no. 5, pp. 1202–1210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. S. T. Leach, I. Messina, D. A. Lemberg, D. Novick, M. Rubenstein, and A. S. Day, “Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 14, no. 1, pp. 68–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  147. K. Sato, M. Shiota, S. Fukuda et al., “Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a dna-based biomarker for susceptibility to crohn's disease in the japanese population,” Journal of Clinical Immunology, vol. 29, no. 6, pp. 815–825, 2009. View at Publisher · View at Google Scholar · View at Scopus
  148. K. Wang, S. P. Dickson, C. A. Stolle, I. D. Krantz, D. B. Goldstein, and H. Hakonarson, “Interpretation of association signals and identification of causal variants from genome-wide association studies,” American Journal of Human Genetics, vol. 86, no. 5, pp. 730–742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  149. J. P. Hugot, M. Chamaillard, H. Zouali et al., “Association of nod2 leucine-rich repeat variants with susceptibility to crohn's disease,” Nature, vol. 411, no. 6837, pp. 599–603, 2001. View at Publisher · View at Google Scholar · View at Scopus
  150. Y. Ogura, D. K. Bonen, N. Inohara et al., “A frameshift mutation in nod2 associated with susceptibility to crohn's disease,” Nature, vol. 411, no. 6837, pp. 603–606, 2001. View at Publisher · View at Google Scholar · View at Scopus
  151. J. H. Cho and C. T. Weaver, “The genetics of inflammatory bowel disease,” Gastroenterology, vol. 133, no. 4, pp. 1327–1339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  152. P. R. Burton, D. G. Clayton, L. R. Cardon et al., “Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls,” Nature, vol. 447, no. 7145, pp. 661–678, 2007. View at Publisher · View at Google Scholar · View at Scopus
  153. C. A. Anderson, N. Soranzo, E. Zeggini, and J. C. Barrett, “Synthetic associations are unlikely to account for many common disease genome-wide association signals,” Plos Biology, vol. 9, no. 1, Article ID e1000580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  154. M. A. Lee-Kirsch, M. Gong, D. Chowdhury et al., “Mutations in the gene encoding the 3′-5′ dna exonuclease trex1 are associated with systemic lupus erythematosus,” Nature Genetics, vol. 39, no. 9, pp. 1065–1067, 2007. View at Publisher · View at Google Scholar · View at Scopus
  155. Y. J. Crow and J. Rehwinkel, “Aicardi-goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity,” Human Molecular Genetics, vol. 18, no. 2, pp. R130–136, 2009. View at Google Scholar · View at Scopus
  156. D. B. Stetson, J. S. Ko, T. Heidmann, and R. Medzhitov, “Trex1 prevents cell-intrinsic initiation of autoimmunity,” Cell, vol. 134, no. 4, pp. 587–598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  157. Y. J. Crow, B. E. Hayward, R. Parmar et al., “Mutations in the gene encoding the 3′-5′ dna exonuclease trex1 cause aicardi-goutières syndrome at the ags1 locus,” Nature Genetics, vol. 38, no. 8, pp. 917–920, 2006. View at Publisher · View at Google Scholar · View at Scopus
  158. M. Morita, G. Stamp, P. Robins et al., “Gene-targeted mice lacking the trex1 (dnase iii) 3′→5′ dna exonuclease develop inflammatory myocarditis,” Molecular and Cellular Biology, vol. 24, no. 15, pp. 6719–6727, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. F. Goutières, J. Aicardi, P. G. Barth, and P. Lebon, “Aicardi-goutieres syndrome: an update and results of interferon-α studies,” Annals of Neurology, vol. 44, no. 6, pp. 900–907, 1998. View at Google Scholar · View at Scopus
  160. P. Lebon, J. Badoual, G. Ponsot, F. Goutieres, F. Hemeury-Cukier, and J. Aicardi, “Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy,” Journal of the Neurological Sciences, vol. 84, no. 2-3, pp. 201–208, 1988. View at Google Scholar · View at Scopus
  161. R. C. Dale, S. Ping Tang, J. Z. Heckmatt, and F. M. Tatnall, “Familial systemic lupus erythematosus and congenital infection-like syndrome,” Neuropediatrics, vol. 31, no. 3, pp. 155–158, 2000. View at Publisher · View at Google Scholar · View at Scopus
  162. M. K. Crow, “Developments in the clinical understanding of lupus,” Arthritis Research and Therapy, vol. 11, no. 5, article no. 245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. G. Rice, T. Patrick, R. Parmar et al., “Clinical and molecular phenotype of aicardi-goutières syndrome,” American Journal of Human Genetics, vol. 81, no. 4, pp. 713–725, 2007. View at Publisher · View at Google Scholar · View at Scopus
  164. U. De Silva, S. Choudhury, S. L. Bailey, S. Harvey, F. W. Perrino, and T. Hollis, “The crystal structure of trex1 explains the 3′ nucleotide specificity and reveals a polyproline ii helix for protein partnering,” Journal of Biological Chemistry, vol. 282, no. 14, pp. 10537–10543, 2007. View at Publisher · View at Google Scholar · View at Scopus
  165. B. Namjou, P. H. Kothari, J. A. Kelly et al., “Evaluation of the trex1 gene in a large multi-ancestral lupus cohort,” Genes and Immunity, vol. 12, no. 4, pp. 270–279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  166. M. A. Lee-Kirsch, M. Gong, H. Schulz et al., “Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p,” American Journal of Human Genetics, vol. 79, no. 4, pp. 731–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. A. Qari, S. Al-Mayouf, and M. Al-Owain, “Mode of inheritance in systemic lupus erythematosus in saudi multiplex families,” Genetic Counseling, vol. 20, no. 3, pp. 215–223, 2009. View at Google Scholar · View at Scopus
  168. G. J. Lyon, T. Jiang, R. Van Wijk et al., “Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications,” Discovery Medicine, vol. 12, no. 62, pp. 41–55, 2011. View at Google Scholar
  169. A. Rope, K. Wang, R. Evjenth et al., “Using vaast to identify an x-linked disorder resulting in lethality in male infants due to n-terminal acetyltransferase deficiency,” American Journal of Human Genetics, 2011. View at Publisher · View at Google Scholar · View at Scopus
  170. B. De Vries, G. M. Steup-Beekman, J. Haan et al., “Trex1 gene variant in neuropsychiatric systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 69, no. 10, pp. 1886–1887, 2010. View at Publisher · View at Google Scholar · View at Scopus
  171. J. T. Glessner, K. Wang, G. Cai et al., “Autism genome-wide copy number variation reveals ubiquitin and neuronal genes,” Nature, vol. 459, no. 7246, pp. 569–572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  172. J. T. Glessner, M. P. Reilly, C. E. Kim et al., “Strong synaptic transmission impact by copy number variations in schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 23, pp. 10584–10589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  173. D. F. Levinson, J. Duan, S. Oh et al., “Copy number variants in schizophrenia: confirmation of five previous finding sand new evidence for 3q29 microdeletions and vipr2 duplications,” American Journal of Psychiatry, vol. 168, no. 3, pp. 302–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  174. S. J. Diskin, C. Hou, J. T. Glessner et al., “Copy number variation at 1q21.1 associated with neuroblastoma,” Nature, vol. 459, no. 7249, pp. 987–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  175. W. Gu, F. Zhang, and J. R. Lupski, “Mechanisms for human genomic rearrangements,” Pathogenetics, vol. 1, no. 1, p. 4, 2008. View at Google Scholar
  176. D. L. Altshuler, R. M. Durbin, G. R. Abecasis et al., “A map of human genome variation from population-scale sequencing,” Nature, vol. 467, no. 7319, pp. 1061–1073, 2010. View at Publisher · View at Google Scholar · View at Scopus
  177. D. F. Conrad, D. Pinto, R. Redon et al., “Origins and functional impact of copy number variation in the human genome,” Nature, vol. 464, no. 7289, pp. 704–712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. A. W. Pang, J. R. MacDonald, D. Pinto et al., “Towards a comprehensive structural variation map of an individual human genome,” Genome Biology, vol. 11, no. 5, article no. R52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. T. J. Aitman, R. Dong, T. J. Vyse et al., “Copy number polymorphism in fcgr3 predisposes to glomerulonephritis in rats and humans,” Nature, vol. 439, no. 7078, pp. 851–855, 2006. View at Publisher · View at Google Scholar · View at Scopus
  180. M. Fanciulli, P. J. Norsworthy, E. Petretto et al., “Fcgr3b copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity,” Nature Genetics, vol. 39, no. 6, pp. 721–723, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. M. Molokhia, M. Fanciulli, E. Petretto et al., “Fcgr3b copy number variation is associated with systemic lupus erythematosus risk in afro-caribbeans,” Rheumatology, vol. 50, no. 7, Article ID keq456, pp. 1206–1210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  182. D. L. Morris, A. L. Roberts, A. S. Witherden et al., “Evidence for both copy number and allelic (NA1/NA2) risk at the fcgr3b locus in systemic lupus erythematosus,” European Journal of Human Genetics, vol. 18, no. 9, pp. 1027–1031, 2010. View at Publisher · View at Google Scholar · View at Scopus
  183. A. J. E. Seely, J. L. Pascual, and N. V. Christou, “Science review: cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance,” Critical Care, vol. 7, no. 4, pp. 291–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  184. S. Yamashiro, H. Kamohara, J. M. Wang, D. Yang, W. H. Gong, and T. Yoshimura, “Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses,” Journal of Leukocyte Biology, vol. 69, no. 5, pp. 698–704, 2001. View at Google Scholar · View at Scopus
  185. B. Gregory, A. Kirchem, S. Phipps et al., “Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression,” The Journal of Immunology, vol. 170, no. 11, pp. 5359–5366, 2003. View at Google Scholar
  186. B. Yu, Y. Shao, X. Yue et al., “Copy number variations of interleukin-12b and t-bet are associated with systemic lupus erythematosus,” Rheumatology, vol. 50, no. 7, Article ID keq439, pp. 1201–1205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  187. B. Yu, Y. Shao, P. Li et al., “Copy number variations of the human histamine h4 receptor gene are associated with systemic lupus erythematosus,” British Journal of Dermatology, vol. 163, no. 5, pp. 935–940, 2010. View at Publisher · View at Google Scholar · View at Scopus
  188. H. Garcia-Ortiz, R. Velazquez-Cruz, F. Espinosa-Rosales, S. Jimenez-Morales, V. Baca, and L. Orozco, “Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population,” Annals of the Rheumatic Diseases, vol. 69, no. 10, pp. 1861–1865, 2010. View at Google Scholar
  189. M. M. A. Fernando, A. J. de Smith, L. Coin et al., “Investigation of the hin200 locus in uk sle families identifies novel copy number variants,” Annals of Human Genetics, vol. 75, no. 3, pp. 383–397, 2011. View at Publisher · View at Google Scholar · View at Scopus